Determinants of quality of life in patients near the end of life: A longitudinal perspective

Carla P. Hermann, Stephen W. Looney

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose/Objectives: To describe the quality of life (QOL) of patients near the end of life and to identify determinants of their QOL. Design: Descriptive, longitudinal. Setting: University-affiliated cancer center, two private oncologists' offices, and patients' homes. Sample: 80 patients with either stage IIIb or IV lung cancer newly diagnosed in the previous month or recurrent lung cancer with distant disease. Methods: Patients were interviewed for responses to instruments to assess demographic, physical, psychosocial, and spiritual characteristics. Baseline data were collected at the patients' places of oncology care. Home visits were made for the two-month and four-month data collection points. Main Research Variables: QOL; symptom frequency, severity, and distress; functional status; anxiety; depression. Findings: Fifty percent of patients died within five months of their lung cancer diagnosis. Patients reported a relatively high QOL that did not change significantly as they approached the end of life. Symptom distress was the strongest determinant of QOL, followed by symptom severity, symptom frequency, and depression. Conclusions: QOL was most affected by symptoms experienced in patients with advanced lung cancer, particularly distress associated with symptoms. Interventions for symptom management must be implemented at diagnosis because patients in this population may approach the end of life quickly. Implications for Nursing: A routine and thorough symptom assessment is imperative for patients with advanced lung cancer. Attention to symptom distress is important because of its effect on QOL.

Original languageEnglish (US)
Pages (from-to)23-31
Number of pages9
JournalOncology nursing forum
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Quality of Life
Lung Neoplasms
Depression
House Calls
Symptom Assessment
Nursing
Anxiety
Demography
Research
Population
Neoplasms

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Determinants of quality of life in patients near the end of life : A longitudinal perspective. / Hermann, Carla P.; Looney, Stephen W.

In: Oncology nursing forum, Vol. 38, No. 1, 01.01.2011, p. 23-31.

Research output: Contribution to journalArticle

@article{6cfe41bca5a443358dc64b449a76f88a,
title = "Determinants of quality of life in patients near the end of life: A longitudinal perspective",
abstract = "Purpose/Objectives: To describe the quality of life (QOL) of patients near the end of life and to identify determinants of their QOL. Design: Descriptive, longitudinal. Setting: University-affiliated cancer center, two private oncologists' offices, and patients' homes. Sample: 80 patients with either stage IIIb or IV lung cancer newly diagnosed in the previous month or recurrent lung cancer with distant disease. Methods: Patients were interviewed for responses to instruments to assess demographic, physical, psychosocial, and spiritual characteristics. Baseline data were collected at the patients' places of oncology care. Home visits were made for the two-month and four-month data collection points. Main Research Variables: QOL; symptom frequency, severity, and distress; functional status; anxiety; depression. Findings: Fifty percent of patients died within five months of their lung cancer diagnosis. Patients reported a relatively high QOL that did not change significantly as they approached the end of life. Symptom distress was the strongest determinant of QOL, followed by symptom severity, symptom frequency, and depression. Conclusions: QOL was most affected by symptoms experienced in patients with advanced lung cancer, particularly distress associated with symptoms. Interventions for symptom management must be implemented at diagnosis because patients in this population may approach the end of life quickly. Implications for Nursing: A routine and thorough symptom assessment is imperative for patients with advanced lung cancer. Attention to symptom distress is important because of its effect on QOL.",
author = "Hermann, {Carla P.} and Looney, {Stephen W.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1188/11.ONF.23-31",
language = "English (US)",
volume = "38",
pages = "23--31",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "1",

}

TY - JOUR

T1 - Determinants of quality of life in patients near the end of life

T2 - A longitudinal perspective

AU - Hermann, Carla P.

AU - Looney, Stephen W.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Purpose/Objectives: To describe the quality of life (QOL) of patients near the end of life and to identify determinants of their QOL. Design: Descriptive, longitudinal. Setting: University-affiliated cancer center, two private oncologists' offices, and patients' homes. Sample: 80 patients with either stage IIIb or IV lung cancer newly diagnosed in the previous month or recurrent lung cancer with distant disease. Methods: Patients were interviewed for responses to instruments to assess demographic, physical, psychosocial, and spiritual characteristics. Baseline data were collected at the patients' places of oncology care. Home visits were made for the two-month and four-month data collection points. Main Research Variables: QOL; symptom frequency, severity, and distress; functional status; anxiety; depression. Findings: Fifty percent of patients died within five months of their lung cancer diagnosis. Patients reported a relatively high QOL that did not change significantly as they approached the end of life. Symptom distress was the strongest determinant of QOL, followed by symptom severity, symptom frequency, and depression. Conclusions: QOL was most affected by symptoms experienced in patients with advanced lung cancer, particularly distress associated with symptoms. Interventions for symptom management must be implemented at diagnosis because patients in this population may approach the end of life quickly. Implications for Nursing: A routine and thorough symptom assessment is imperative for patients with advanced lung cancer. Attention to symptom distress is important because of its effect on QOL.

AB - Purpose/Objectives: To describe the quality of life (QOL) of patients near the end of life and to identify determinants of their QOL. Design: Descriptive, longitudinal. Setting: University-affiliated cancer center, two private oncologists' offices, and patients' homes. Sample: 80 patients with either stage IIIb or IV lung cancer newly diagnosed in the previous month or recurrent lung cancer with distant disease. Methods: Patients were interviewed for responses to instruments to assess demographic, physical, psychosocial, and spiritual characteristics. Baseline data were collected at the patients' places of oncology care. Home visits were made for the two-month and four-month data collection points. Main Research Variables: QOL; symptom frequency, severity, and distress; functional status; anxiety; depression. Findings: Fifty percent of patients died within five months of their lung cancer diagnosis. Patients reported a relatively high QOL that did not change significantly as they approached the end of life. Symptom distress was the strongest determinant of QOL, followed by symptom severity, symptom frequency, and depression. Conclusions: QOL was most affected by symptoms experienced in patients with advanced lung cancer, particularly distress associated with symptoms. Interventions for symptom management must be implemented at diagnosis because patients in this population may approach the end of life quickly. Implications for Nursing: A routine and thorough symptom assessment is imperative for patients with advanced lung cancer. Attention to symptom distress is important because of its effect on QOL.

UR - http://www.scopus.com/inward/record.url?scp=79953118162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953118162&partnerID=8YFLogxK

U2 - 10.1188/11.ONF.23-31

DO - 10.1188/11.ONF.23-31

M3 - Article

C2 - 21186157

AN - SCOPUS:79953118162

VL - 38

SP - 23

EP - 31

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 1

ER -